the complexity of the A. fumigatus proteome, it is not known against which fungal Ags human T cells predominantly react and which T cell specificities are protective. In addition, it is not clear whether regulatory T cells (Tregs), which represent the major part of the human T cell response against A. fumigatus (17), recognize the same or different Ags as do their conventional T cell (Tcon) counterparts.
The A. fumigatus genome contains several thousand open reading frames encoding potential antigenic proteins. The initially inhaled resting conidia (RC) convert to swollen conidia (SC) within 4-5 h upon arrival in the lungs and germinate to form germ tubes and, later, hyphae (18) . Proteomic approaches revealed differences in the most abundant proteins present in conidia and hyphae (19) (20) (21) . Therefore, further variability in potential T cell Ags may result from the morphogenic status of the fungus at the time of encounter with the immune system, which might significantly impact the generation of a specific T cell response. Thus, identification of the main in vivo T cell targets (i.e., proteins derived from the different morphogenic stages and subcellular structures), as well as knowledge about their Tcon-or Treg-activating potential, would have important implications for vaccination or adoptive cell therapy strategies.
We recently described a highly specific and sensitive assay to enumerate and characterize Ag-specific CD4 + T cells directly ex vivo based on CD154 + pre-enrichment (Ag-reactive T cell enrichment [ARTE]) (12, 22) . We used ARTE to systematically quantify and characterize the very rare human peripheral CD4 + T cells reacting against crude lysates of A. fumigatus, as well as selected proteins or protein fractions. We found that the T cell response against A. fumigatus is highly diverse, calling into question the existence of one or a few immunodominant A. fumigatus Ags. However, we identified quantitative and qualitative differences within the single-protein-specific T cell populations, which may provide a general screening procedure to classify fungal Ags and identify potentially immunogenic in vivo targets.
Materials and Methods

Blood donors
Buffy coats from healthy donors were obtained from the Institute for Transfusion Medicine, University Hospital Dortmund, Dortmund, Germany. after informed consent. PBMCs were isolated by Ficoll-Paque (GE Healthcare Life Sciences, Freiburg, Germany) density gradient centrifugation.
Preparation of A. fumigatus lysates
For the generation of all A. fumigatus [strain ATCC46645, CEA10 and DrodA (23) ] protein extracts, with the exception of the lysate of RC, 2 3 10 8 conidia were inoculated in 200 ml yeast extract-peptone-dextrose medium and cultured at 37˚C and 200 rpm. SC, germinating conidia (GC), and mycelium were harvested after 6, 8, or 20 h of cultivation, respectively. Cells were recovered by centrifugation (RC, SC, GC) or filtration (mycelium) and washed with water before storage at 280˚C. Total RC, SC, or GC lysates were generated by disruption of frozen cells in saline (0.9% [w/v] NaCl) using a Mikro-Dismembrator (Sartorius). For total mycelial lysate, frozen mycelium was ground in liquid nitrogen using a mortar and pestle and resuspended in PBS supplemented with 2 mM MgCl 2 . Total soluble protein fractions of the lysates (crude lysates) were obtained after removal of insoluble material (cell wall pellet) by centrifugation for 15 min at 10,000 3 g. Fractionated mycelial protein extracts were obtained by standard protocols using sequential centrifugation of total mycelial lysate (24) . The cell wall protein fraction was processed by washing the cell wall pellet (15 min of centrifugation at 10,000 3 g) three times with PBS/2 mM MgCl 2 and resuspending the pellet in the same buffer. The cell membrane-enriched protein fraction (pellet) was separated from the cytosolic protein fraction by centrifugation of the crude mycelial lysate at 100,000 3 g for 60 min. Cell membrane extract was generated by washing the membrane pellet in PBS/2 mM MgCl 2 , recentrifuging for 45 min, and resuspending the membrane pellet in the same buffer.
Generation of recombinant A. fumigatus proteins
The recombinant Crf2 (AFUA_1G16190) protein was generated as described (25) . The recombinant GliT protein (AFUA_6G09740) was produced in E. coli and purified as described (26) . The open reading frames of the genes scw4 (AFUA_6G12380), aspf3 (AFUA_6G02280), shm2 (AFUA_3G09320), cpcB (AFUA_4G13170), and aspf22 (AFUA_6G06770) were amplified from ATCC46645 cDNA and cloned into the expression vector pET43.1H6 for recombinant expression as His-tagged proteins. For pst1 (AFUA_6G10290), a truncated version was generated by omitting the sequence that encodes the first 17 aa of the N-terminal secretion signal peptide. The truncated pst1 cDNA and the open reading frame of triosephosphate isomerase TpiA (AFUA_5G13450) were cloned into a pMalC2HTEV vector (27) for recombinant production as N-terminal MBP-His-tagged proteins. After transformation of Escherichia coli BL21 (DE3), all proteins were expressed by autoinduction in Overnight Express Instant TB medium (Novagen) at 30˚C for 24 h. E. coli cells were harvested by centrifugation, homogenized in TBS (20 mM Tris-HCl [pH 8], 150 mM NaCl, 1 mM DTT, 1 mM PMSF for Pst1, TpiA, and AspF3), TBS complemented with 8 M urea (for Scw4), TBS complemented with 10% (v/v) glycerol (for AspF22), or phosphate buffer (50 mM NaP [pH 8], 300 mM NaCl, 1 mM DTT, 1 mM PMSF for Shm2 and CpcB) and lysed using an EmulsiFlex-C5 high pressure homogenizer (Avestin). The coding sequence of the FG-GAP repeat protein (AGUA_1G04130) and of AspF2 (AFUA_4G09580), which were devoid of the sequence encoding the 25 respectively the 17 aa N-terminal secretion signal peptide (Δ25FG-GAP and Δ17AspF2), were amplified and cloned into the expression vector pPICZaB. After transformation of Pichia pastoris (strain X-33), culturing of cells and induction of expression were conducted according to the Pichia Expression Kit manual (Life Technologies, Darmstadt, Germany). Culture supernatants containing the secreted His-tagged recombinant proteins were collected after 48 h of expression and diluted (1:5) into binding buffer (10 mM NaP [pH 7.4], 500 mM NaCl, 10 mM imidazole).
All proteins were purified by affinity chromatography using an Ä kta explorer purification system (GE Healthcare). If necessary, an ion exchange column (SOURCE 15Q; GE Healthcare) was used for further purification. Generally, all buffer exchanges were conducted using HiPrep 26/10 desalting columns (GE Healthcare). All His-tagged proteins were applied to a Ni Sepharose 6 Fast Flow (GE Healthcare) column and eluted with 250 mM imidazole. Maltose-binding protein (MBP)-tagged proteins were loaded onto an Amylose Resin HF (New England Biolabs) column and eluted with 10 mM maltose. The MBP-His tag of MBP-tagged proteins and the His tag of AspF3 were cleaved using TEV-protease and removed by its binding to Ni Sepharose. After buffer exchange to 20 mM Tris-HCl [pH 8] (CpcB, Pst1, TpiA) or 20 mM Tris-HCl [pH 8.5] 6 M urea (Scw4), the corresponding proteins were purified further by ion-exchange chromatography using an NaCl gradient for elution. Scw4 was purified further by reversed-phase chromatography (Source 15RPC; GE Healthcare) after exchanging the buffer to 0.05% (v/v) trifluoroacetic acid, 10% (v/v) acetonitrile. Purified Scw4 was lyophilized and resolved in PBS. For all other purified proteins, the buffer was exchanged to PBS (FG-GAP, Pst1, AspF22, AspF2, GliT) or 0.9% (w/v) NaCl (Shm2, CpcB, AspF3, TpiA).
Stimulation of Ag-reactive T cells
PBMCs were resuspended at a concentration of 1 3 10 7 /ml in RPMI 1640 (Miltenyi Biotec, Bergisch Gladbach, Germany), supplemented with 5% (v/v) human AB-serum (BioWhittaker/Lonza, Walkersville, MD) and 2 mM L-glutamine (PAA Laboratories, Pasching, Austria). Cells were stimulated for 7 h with the following Ags: A. fumigatus lysates (each 40 mg/ml), Candida albicans lysate (20 mg/ml; Greer Laboratories, Lenoir, NC), CMV lysate (10 mg/ml; Siemens Healthcare Diagnostics, Marburg, Germany), recombinant A. fumigatus proteins (Crf2, Pst1, Aspf2, Aspf3, Shm2, FG-GAP, GliT, Aspf22, CpcB, TpiA, Scw4; each 20 mg/ml) or peptide pools (C. albicans MP65, Gel1, Crf1, Aspf3, CatB, Sod3, Shm2; each 0.6 nmol/peptide/ml; all from Miltenyi Biotec), or pools of proteins based on their classification as immunogenic (Scw4, CRF1, CRF2, Pst1, Shm2; each 20 mg/ml), nontarget (Gel1, CatB; each 20 mg/ml), or exhausting (Aspf2, CpcB, Aspf3, FG-GAP; each 20 mg/ml). A total of 1 mg/ml CD40 and 1 mg/ml CD28 functional-grade pure Ab (both from Miltenyi Biotec) was added. In some experiments, CD45RA + cells were depleted from PBMCs prior to stimulation using CD45RA MicroBeads and LD columns (Miltenyi Biotec).
Miltenyi Biotec). In brief, cells were indirectly magnetically labeled with CD154-biotin and CD137-PE, followed by anti-biotin MicroBeads and anti-PE MicroBeads and enriched by two sequential MS MACS columns (Miltenyi Biotec). For analysis of cytokine expression, 1 mg/ml brefeldin A (Sigma-Aldrich) was added for the last 2 h of stimulation. Surface staining was performed on the first column, followed by fixation, permeabilization (Inside Stain Kit; Miltenyi Biotec), and intracellular cytokine staining on the second column, as described (12) , or staining of Foxp3 using the Foxp3 Staining Buffer Set (Miltenyi Biotec).
In vitro expansion and restimulation of Ag-reactive T cell lines
Magnetically enriched CD154
+ T cells were expanded with 1:100 mitomycin C (Sigma-Aldrich)-treated autologous feeder cells in X-VIVO 15 (BioWhittaker/Lonza), supplemented with 5% (v/v) AB-serum (BioWhittaker/ Lonza), 200 U/ml IL-2 (Proleukin; Novartis, N€ urnberg, Germany), and 100 U/ml penicillin, 100 mg/ml streptomycin, and 0.25 mg/ml amphotericin B (Antibiotic Antimycotic Solution; Sigma-Aldrich) at a density of 2.5 3 10 6 cells/cm 2 . During expansion for 2-3 wk, medium was replenished, and cells were split as needed.
A total of 5 3 10 5 expanded T cells was restimulated with autologous CD3-depleted (CD3 MicroBeads; Miltenyi Biotec) PBMCs at a 1:1 ratio in 96-well flat-bottom plates with different Ags in the presence of 1 mg/ml CD28 functional-grade pure Ab for 2 h and for an additional 4 h with 1 mg/ml brefeldin A. Following fixation and permeabilization, cells were stained intracellularly for CD154 and cytokines.
Flow cytometry
Different combinations of the following mAbs were used according to the manufacturer's recommendations: CD4-VioBlue, CD4-FITC, CD4-allo- 
Statistical analysis
Statistical tests were performed with GraphPad PRISM software 5.0 (GraphPad, La Jolla, CA) using one-way ANOVA. The p values , 0.05 were considered statistically significant.
Results
Human CD4
+ T cell response against lysates of different A. fumigatus morphotypes
CD4
+ T cells specifically reacting against A. fumigatus can be identified using CD154 expression as a specific read-out for Agactivated CD4 + T cells after short in vitro stimulation with fungal lysate (12, 22) . To analyze against which A. fumigatus morphotype the human T cell response is directed, PBMCs from healthy donors were stimulated for 7 h with crude lysates from RC, SC, GC, or mycelia containing the total soluble fraction of the mechanically disrupted fungal cells. Reactive CD154-expressing CD4 + T cells were identified by flow cytometry. Although all lysates induced a small population of CD154-expressing CD4 + T cells, the frequency of reactive cells stimulated with RC lysate was significantly lower compared with stimulation with lysates from other morphotypes (Fig. 1A, 1B) . To enable the direct ex vivo phenotypic and functional characterization of the specific T cells, we next magnetically pre-enriched the rare Ag-reactive CD154 + T cells from larger cell numbers (1 3 10 7 PBMCs) (12).
Again, a significantly higher number of target cells could be detected after stimulation with lysates from the more progressed development stages compared with the RC lysate (Fig. 1C) . Resting A. fumigatus spores were demonstrated to be covered by a RodA hydrophobin layer that prevents immune recognition (28, 29) . However, we observed no differences in the T cell reactivity against RC lysates of a RodA-knockout strain when using the total soluble fraction of the mechanically disrupted conidia (Supplemental Fig. 1 ). Further analysis of cytokine production and phenotype revealed no major differences in the T cells stimulated with the different A. fumigatus morphotype lysates; as shown in Fig. 1D , with all lysates a high frequency of TNF-a and IL-2 producers could be detected, whereas production of the lineage-defining cytokines IFN-g and IL-17 was typically ,10%, although IFN-g production was clearly predominant over IL-17, as described previously (12, 30, 31) . Similarly, irrespective of the A. fumigatus lysate used for stimulation, a comparable number of reactive CD45RO + memory T cells was detected (Fig. 1E ), whereas the remaining CD154 + cells had a naive phenotype (CD45RA + CCR7
2 ; lack of effector cytokine production), as shown previously (12, 17) . In summary, these results demonstrate that reactive memory CD4 + T cells against the different morphotypes of A. fumigatus (RC, SC, GC, mycelia) are present in healthy human donors and suggest that the strongest T cell response is directed against the actively growing fungus.
SC and GC, as well as mycelia, contain overlapping T cell Ags
We next addressed whether the reactive CD4 + T cells recognize different or the same Ags expressed by the various A. fumigatus morphotypes. To this end, specific T cell lines were generated by expanding the magnetically enriched CD154 + T cells after stimulation with the different morphotype lysates. Upon restimulation, the T cell lines initially stimulated with protein extracts of SC, GC, and mycelia were equally reactive to each lysate, as shown by re-expression of CD154 and production of cytokines ( Fig. 2A,  2B ). However, the T cell reactivity upon restimulation with RC lysate was significantly lower in each case, suggesting that a considerable proportion of T cell Ags, which are present in the metabolically active morphotypes (SC, GC, mycelia), are missing in the RC lysate. Furthermore, RC-reactive T cell lines reacted equally well to restimulation with all the different morphotype lysates, suggesting that RC do not contain a significant fraction of T cell target proteins solely present in the dormant stage. As expected, none of the expanded cell lines reacted upon restimulation with CMV lysate as a control Ag, providing evidence for the specificity of the expanded fungus-reactive T cell lines. As for the ex vivo response, we observed no differences in the cytokineproducing capacities of the different T cell lines upon restimulation (Fig. 2C) .
A large proportion of the human A. fumigatus-specific T cell response is elicited by mycelial membrane proteins Because restimulation of the expanded A. fumigatus-reactive T cell lines revealed a comparable and largely overlapping T cell Ag repertoire of SC and GC or mycelial lysate, we focused on the mycelial morphotype for further experiments. The first encounter with the immune system occurs with A. fumigatus proteins located on the cell surface, which include secreted, cell wall, and membrane proteins. Therefore, we analyzed whether the Ag-specific T cell response differs in response to distinct subcellular fractions of A. fumigatus mycelia. Lysates were generated from the mycelial cell wall, membrane, or cytosolic fraction and compared with the crude mycelial extract, as applied in the above-described experiments. Interestingly, the level of ex vivo stimulation of PBMCs with the cell wall or cytosolic fraction was lower compared with stimulation with the crude mycelial lysate. In contrast, stimulation with the membrane fraction (100,000 3 g pellet) yielded similar frequencies and numbers of CD154 + cells compared with the crude extract (Fig. 3A, 3B ). However, again we observed no major differences in the ex vivo CD45RO + memory phenotype of T cells stimulated with the different cellular fractions (Fig. 3C) , indicating the existence of specific human memory T cells against components from all of the mycelial compartments.
To further corroborate the finding that a large proportion of the specific T cell repertoire against A. fumigatus is directed against mycelial membrane proteins, cell lines were expanded from initially crude extract-or membrane fraction-stimulated CD154 + T cells. Restimulation confirmed that the highest reactivity was obtained with lysate of the membrane fraction, whereas restimulation with the cell wall or cytosolic fraction revealed a lower T cell reactivity (Fig. 3D, 3E) .
In summary, these results revealed a broad and variable T cell response against different morphotypes and cellular fractions of A. fumigatus, but they identified the mycelial membrane proteins as a major target of the A. fumigatus-specific T cell response in healthy human donors.
ARTE allows direct characterization of human CD4
+ T cells reacting against single A. fumigatus proteins Until now, only a few single proteins of A. fumigatus have been analyzed and directly compared with regard to their capacity to elicit CD4 + T cell responses in humans (31) (32) (33) . In particular, the direct ex vivo qualitative and quantitative characterization of the responding T cells, which avoids an experimental bias due to prolonged in vitro culture, has been lacking so far. However, the quality of the T cell response generated in vivo may provide important insight into the immunogenic properties of specific antigenic proteins.
Therefore, we performed multiparameter analysis of the T cells specific for a panel of 15 selected A. fumigatus proteins with different biological functions and cellular localization. Either recombinant proteins or synthesized 15mer peptide pools covering the complete protein sequence were used for stimulation. The analyzed proteins included cell wall, GPI-anchored, secreted, and cytosolic proteins and were chosen based on their high abundance within the conidial, mycelial, or secreted proteome and/or their previous characterization as being immunogenic, based on T cell or serum reactivity (Table I) . A concentration of 20 mg/ml of recombinant proteins for the stimulation of 1 3 10 7 PBMCs was determined based on titration of the single proteins on expanded total mycelia-reactive T cell lines (Supplemental Fig. 2) . The C. albicans protein MP65 was described to be a major Ag target of human T cell responses (34, 35) and served as a positive control.
Following stimulation with the single A. fumigatus proteins, no reactive CD4 + T cells above background could be detected by standard flow cytometric counting without pre-enrichment (data not shown). To enable the direct ex vivo detection of reactive CD4 + T cells against the single A. fumigatus proteins, we performed ARTE using 1 3 10 7 stimulated PBMCs. Although the frequencies upon single-protein stimulation were significantly lower, as upon stimulation with A. fumigatus or C. albicans crude lysates, specific T cells against single proteins could be clearly detected compared with the nonstimulated control (Fig. 4A) . The specificity of the ex vivo-detected single-protein-reactive CD154 + T cells was confirmed by expansion and restimulation of specific T cell lines (Supplemental Fig. 3) .
Interestingly, the T cell responses against the different proteins were quite variable, with frequencies ranging from 1.2 3 10 26 to 3.1 3 10 24 (Fig. 4B) , and showed strong intra-and interdonor variability (Fig. 4) . As expected, this indicates an overall diverse repertoire of A. fumigatus-reactive CD4 + T cells, probably due to different exposure and/or HLA restriction. The subcellular location of the proteins did not result in a clear-cut phenotypic/ functional characteristic of the resulting T cell response, although a trend toward a strong reactivity against membrane-associated proteins was observed.
Integration of phenotypic and functional markers of specific T cells allows classification of antigenic proteins
Because our method allows multiparameter characterization of very rare single A. fumigatus protein-specific T cells, we integrated cytokine production, as well as phenotypic T cell markers, into our subsequent analyses (Fig. 5 ). The combination of frequencies, naive/ memory distribution, and effector cytokine production allowed classification of the fungal proteins into three groups. "Immunogenic" proteins are characterized by high overall T cell frequencies, primarily memory-type cells, and high IFN-g and/or IL-17 production. In contrast, "exhausting" proteins were characterized by their low to intermediate overall frequencies and lack of effector cytokine production, although the majority of cells had a clear memory phenotype. Also, no other effector cytokines (i.e., IL-4, IL-9, IL-10, IL-13, and IL-22) were produced by the reactive memory cells after stimulation with a pool of all proteins from this group (Supplemental Fig. 4 ). These properties are characteristic of deletion and/or anergy of specific T cells. These two groups with obvious immune reactivity in vivo contrast with the third group, which we termed "nontarget" proteins, because they induce high overall T cell frequencies; however, strikingly, a large proportion of the cells is still in the naive state and also lacks effector cytokine production. This finding indicates that no immune reactivity is induced in vivo. Interestingly, reactivity against the mycelial crude lysate (Fig. 5) is also characterized by a high frequency of naive T cells and rather low effector cell frequencies compared with the immunogenic protein group, suggesting that a large fraction of the fungal proteins actually belongs to the exhausting or nontarget group. The coproduction of TNF-a, IL-2, and IFN-g was proposed as a marker for multifunctionality of CD4 + T cells (36) . Analyzing this cytokine combination after stimulation with pools of proteins, based on our classification into immunogenic (containing proteins with the highest reactivity: Scw4, Crf1, Crf2, Pst1, Shm2), nontarget (Gel1, CatB), and exhausting (Aspf2, Aspf3, CpcB, Fg-Gap) proteins, confirmed our classification, with the highest proportion of cells being TNF-a + IL-2 + IFN-g + after stimulation with the immunogenic pool (Supplemental Fig. 4B) . T cell responses to single A. fumigatus proteins only account for a small fraction of the total response against A. fumigatus crude lysate in healthy donors To confirm our hypothesis regarding Ag classification and to estimate to what extent the identified immunogenic proteins contribute to the total response in vivo, we generated specific T cell lines from presorted CD4 + CD45RO + memory T cells after stimulation with crude mycelial lysate. The cell lines were retested for their specificity by Ag stimulation with the crude lysate or the single A. fumigatus proteins, as well as a pool thereof (Fig. 6 ). In line with our hypothesis, the main reactivity within the memory cell line was directed against the immunogenic proteins, whereas exhausting or nontarget proteins had only a minimal contribution, with the exception of the FG-GAP repeat protein, which also generated low reactivity in some donors. However, for most proteins, including the immunogenic fraction, only ,1-2% of the expanded CD4 + T cell lines responded upon restimulation with the single proteins. In addition, a high interdonor variability in antigenic targets was observed. However, for some donors, reactivity against certain single proteins exceeded the 1-2% range. This was especially true for the known Ag Aspf22, which generated strong responses in the majority of donor cell lines (mean reactivity 3.6%; range 0-18%).
Taken together, we showed that the human CD4 + T cell response against A. fumigatus is highly heterogeneous and directed against a large number of proteins and epitopes, questioning the existence of one or a few immune-dominant proteins. However, the direct multiparameter analysis of reactive T cells against the single A. fumigatus proteins allows us to predict the immunogenic potential of a particular protein in vivo via integration of frequency, phenotype, and function of specific T cells.
A. fumigatus-specific Tcons and Tregs recognize the same Ags
We recently demonstrated that, surprisingly, A. fumigatus generates a strong Treg response in vivo, which even exceeds conventional memory T cells (Tmems) (17) . Therefore, we analyzed whether the same or different Ags are recognized by A. fumigatus-specific Tmems and Tregs. To this end, the single proteins were pooled according to our previous classification and used for stimulation in comparison with the mycelial crude lysate or the mycelial membrane fraction. CD137, which is expressed by Tregs after 6 h of stimulation, was used together with CD154 enrichment to differentiate between Tregs (CD137 + CD154 2 ) and Tcons (CD137 2 CD154 + ) (17, 37) . As shown in Fig. 7A and 7B, the Treg response mirrored that of Tcons: a high reactivity of specific CD137 + Tregs was found in response to the A. fumigatus crude lysate, as well as the membrane fraction and the immunogenic protein pool. Again, the majority of CD154 + Tcons reactive against the immunogenic and exhausting protein pools displayed a memory phenotype, whereas a larger proportion against the nontarget pool remained in the naive state (Fig. 7C) . This resulted in an equally high Treg/Tmem ratio for all fractions (Fig. 7D) , indicating that A. fumigatus-specific Tregs and Tmems are directed against the same target Ags and that the A. fumigatus-specific T cell response is balanced by specific Tregs.
Discussion
In this study, we show that ARTE can be used for the direct quantification and multiparameter characterization of rare human CD4 + T cells specific for various Ags of the important humanpathogenic fungus A. fumigatus. The sensitivity and flexibility of the method enabled the analysis of T cells specific for various developmental stages, subcellular compartments, as well as a large set of selected single recombinant proteins. Importantly, x (21) x (57) x ( (40) x (21) x (57) x ( x (64) x (64) x ( x (21) x (57) x ( Peptide pool
x (20) x (21) x (57) x ( (57) x (50) -, protein not identified; n.d., not determined; X, protein identified.
the multiparameter characterization of T cells reactive against single A. fumigatus proteins allowed the classification of proteins into immunogenic, exhausting, or nontarget subgroups. Furthermore, our results revealed that the CD4 + T cell response is directed against a broad panel of proteins present in metabolically active fungal morphotypes and that specific Tcons and Tregs are elicited in vivo against the very same Ags.
The presence of A. fumigatus-specific CD4 + T cells in human blood was described in several studies using in vitro-stimulation assays with whole conidia and hyphae, crude lysates, single proteins, or epitopes (12, 13, 30-33, 38, 39) . However, it has not been defined which developmental stage (RC, SC, GC, or mycelia) or subcellular protein fraction primes A. fumigatus-specific T cells in healthy human donors. In this study, we demonstrate that the activated developmental stages of the fungus (SC, GC, and hyphae) contain the largest reservoir of potential T cell epitopes. Furthermore, T cell Ags in the metabolically active A. fumigatus morphotypes were largely overlapping, which is in line with recent results on the proteomic signature of A. fumigatus during early development. These studies showed that the majority of mycelial proteins are also present in all early, metabolically active morphotypes, and only their abundance varied (20, 40, 41) .
The further subcellular dissection of the A. fumigatus mycelia Ags showed that the membrane-bound proteins tended to elicit a stronger T cell reactivity compared to the cytosolic protein fraction, although this did not reach a level of significance. In a recent study by Cagas et al. (24) , the 100,000 3 g fraction primarily contained proteins associated with the plasma membrane, the endoplasmic reticulum, and subcellular organelle membranes. This result was corroborated by the analysis of T cell reactivity against several single A. fumigatus proteins. In this study, we observed a uniformly high frequency of reactive memory-type T cells against all analyzed GPI-anchored membrane proteins, with the exception of Gel1, whereas the exhausting and nontarget groups consist mainly of cytosolic or secreted proteins.
Indeed, the possibility of analyzing the rare T cells reacting against single proteins highlights the potential of ARTE technology, because it allows for the classification of proteins according to their in vivo antigenic potential. So far, CD4 + target proteins primarily have been identified indirectly via the presence of isotype-switched Abs (25, (42) (43) (44) (45) (46) (47) . Alternatively, functional T cell assays, such as proliferation or cytokine production, have been used in a few studies (31-33, 38, 39, 48, 49) but do not allow for quantitative enumeration and phenotypic characterization of the reactive T cells. In fact, for the majority of proteins analyzed, the frequencies of reactive T cells were ,10 24 , which would not be detectable by standard methods. By the parallel assessment of T cell frequency, phenotype, and function, three groups of A. fumigatus proteins could be defined: (1) immunogenic proteins elicited a strong memory response and proinflammatory cytokine production, as well as polyfunctionality in the majority of donors analyzed; (2) in stark contrast, other non-in vivo target proteins elicited a strong in vitro T cell reaction, but the specific T cells were mainly in a naive state, suggesting that the Ag is not presented in vivo; and (3) a large fraction of the analyzed proteins belonged to a third group, which we termed exhausting because the overall frequencies, as well as effector cytokine production, were relatively low, although the majority of reactive cells had a clear memory phenotype. This indicates that Ag encounter takes place in vivo but induces anergy or deletion of the reactive T cells. Thus, the enumeration and multiparameter characterization of T cells specific for single A. fumigatus proteins identifies proteinspecific reactivity patterns and, thus, represent an important complement to the data obtained with mixed Ag preparations.
From the identified immunogenic proteins, Crf1, Sod3, and Aspf22 were described previously to elicit CD4 + T cell responses in humans (31-33, 38) . However, our analysis also identified new immunogenic proteins, including Scw4, Crf2 (25), Pst1, Shm2, GliT, and TpiA, which have not been described as human T cell targets. The gliotoxin oxidase GliT was recently identified via an immunoproteome screening approach and was suggested to represent a novel Ag for serologic diagnosis of aspergillosis (46) . Interestingly, two other "immunogenic" proteins, the enolase Aspf22 and Shm2, were detected in immunoblots using sera from patients with allergic bronchopulmonary aspergillosis (50) . In addition, Shm2 belongs to one of the most abundant proteins identified in the mycelial proteome (21) .
It is important to note that the same characteristics also apply to other proteins that were tested in our study [e.g., CpcB, Aspf2, and Aspf3 (Table I) ], which all belong to the exhausting group. Furthermore, CatB classified by our analysis as a nontarget protein was previously described to induce strong T cell proliferation in vitro, but vaccination with CatB did not protect mice from invasive aspergillosis (32) . Thus, it is obvious that factors other than protein localization, abundance, or Ab reactivity are critical parameters to determine the true in vivo T cell stimulatory capacity and highlights the potential of our approach to systematically predict immunogenic and potential protective target proteins.
In addition to the phenotypic characteristics, ARTE allows the determination of effector functions of the specific T cells, such as production of the functionally important cytokines IFN-g or IL-17. Although IL-17 is frequently claimed to be an important cytokine for antifungal immune responses, its importance in protection against fungal infections versus immunopathology is under debate (51) (52) (53) (54) (55) . In this study, we observed predominant production of IFN-g and only low production of IL-17, which is in line with previous reports (12, 30, 31, 33) suggesting that A. fumigatus predominantly elicits Th1 responses in vivo. Only very low levels of Th2 cytokines (IL-4, IL-5, IL-13) were produced against the defined pools of single proteins (,5% of CD154 + cells) and were typically also ,5% of all reactive CD154 + cells against the total soluble lysate in nonallergic healthy donors (12, 17) . However, when single proteins were analyzed, strong IFN-g and IL-17 cytokine production was only observed against proteins classified as immunogenic. IFN-g was the dominant cytokine against the immunogenic proteins, confirming, also on the level of single proteins, that the in vivo response against A. fumigatus is biased toward a Th1 pattern. Moreover, some proteins (e.g., Scw4, Pst1, GliT, Aspf22) elicited, in addition to IFN-g, the coproduction of relatively high amounts of IL-17. Knowledge about the specific cytokine-induction potential of certain proteins may help to improve vaccine design in the future. However, the functional importance of the various T cell cytokines has to be determined first. Interestingly, by pooling proteins according to our classification, we found that, conventional Tmems, as well as Tregs, were strongly activated by the immunogenic proteins, indicating that Tcons and Tregs recognize the same Ags. In fact, the number of Tregs exactly paralleled the number of Tmems, resulting in a stable Treg/Tmem ratio for all Ags, which is in line with our previous results (17) . This finding indicates that Tregs are not selectively generated against a subgroup of proteins, rather their expansion seems to be coupled to the expansion of Tmems, which may be mediated via growth factor supply, such as IL-2 (56). Thus, the T cell response against all A. fumigatus proteins is controlled by Tregs; therefore, the depletion of Tregs might be a promising strategy for releasing full T cell responses (e.g., for immunotherapeutic approaches).
Finally, despite the fact that our analysis defined a set of immunogenic A. fumigatus proteins, the overall T cell response was directed against a multitude of proteins. In addition, the T cell frequencies against single Ags were very low, and there was significant donor-to-donor variation. This indicates that the A. fumigatus-specific T cell response is largely heterogeneous and is determined by host-specific or environmental factors, such as MHC restriction or variability in the timing and dosage of Ag exposure. In line with this, a recent study identified 7 and 30 T cell epitopes within the Crf1 and CatB protein, respectively, which are presented by different HLA class II molecules (33) . Thus, the existence of a single or even a few immune-dominant Ags is rather unlikely, further emphasizing the importance of technologies allowing the fast ex vivo classification of single proteins or even peptides in individual donors, as demonstrated in this study. 
